Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | %Female (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | American Journal of Transplantation | journal | 3.227 Q1 | 220 | 432 | 1237 | 9769 | 6535 | 1020 | 5.23 | 22.61 | 31.06 | |
2 | Neurotherapeutics | journal | 2.457 Q1 | 136 | 68 | 193 | 6372 | 1459 | 180 | 6.63 | 93.71 | 29.19 | |
3 | Journal of Antimicrobial Chemotherapy | journal | 2.341 Q1 | 221 | 562 | 1565 | 14529 | 7510 | 1220 | 4.76 | 25.85 | 42.05 | |
4 | Orphanet Journal of Rare Diseases | journal | 2.181 Q1 | 136 | 88 | 104 | 4396 | 822 | 104 | 6.59 | 49.95 | 56.05 | |
5 | HIV Medicine | journal | 2.107 Q1 | 86 | 102 | 295 | 3333 | 1148 | 273 | 3.00 | 32.68 | 45.51 | |
6 | International Journal of Neuropsychopharmacology | journal | 1.998 Q1 | 125 | 116 | 370 | 6709 | 1789 | 343 | 4.47 | 57.84 | 38.49 | |
7 | Rheumatology | journal | 1.962 Q1 | 198 | 397 | 1337 | 8715 | 5075 | 956 | 3.52 | 21.95 | 40.98 | |
8 | Drug and Alcohol Dependence | journal | 1.956 Q1 | 187 | 301 | 771 | 13671 | 3262 | 741 | 3.79 | 45.42 | 45.04 | |
9 | AIDS Reviews | journal | 1.932 Q1 | 62 | 28 | 77 | 2316 | 319 | 62 | 3.43 | 82.71 | 33.33 | |
10 | Clinical Pharmacokinetics | journal | 1.861 Q1 | 184 | 61 | 180 | 3425 | 1157 | 165 | 5.84 | 56.15 | 35.26 | |
11 | Drug Safety | journal | 1.803 Q1 | 140 | 96 | 306 | 4277 | 1205 | 243 | 3.78 | 44.55 | 42.75 | |
12 | Alimentary Pharmacology and Therapeutics | journal | 1.759 Q1 | 207 | 399 | 974 | 13226 | 4190 | 849 | 3.87 | 33.15 | 29.68 | |
13 | Cochrane Database of Systematic Reviews | journal | 1.752 Q1 | 327 | 718 | 3055 | 13742 | 14636 | 3055 | 4.88 | 19.14 | 46.75 | |
14 | European Neuropsychopharmacology | journal | 1.625 Q1 | 130 | 99 | 322 | 5365 | 1419 | 317 | 4.16 | 54.19 | 38.68 | |
15 | CNS Drugs | journal | 1.557 Q1 | 129 | 80 | 233 | 6074 | 1417 | 218 | 6.05 | 75.93 | 38.74 | |
16 | Expert Opinion on Investigational Drugs | journal | 1.541 Q1 | 117 | 142 | 487 | 11009 | 2256 | 471 | 4.88 | 77.53 | 28.35 | |
17 | Antiviral Therapy | journal | 1.515 Q1 | 93 | 155 | 424 | 5436 | 1631 | 415 | 3.16 | 35.07 | 43.29 | |
18 | European Archives of Psychiatry and Clinical Neuroscience | journal | 1.494 Q1 | 111 | 92 | 271 | 4026 | 976 | 257 | 3.76 | 43.76 | 35.13 | |
19 | Drugs | journal | 1.490 Q1 | 188 | 144 | 494 | 13027 | 2664 | 460 | 5.62 | 90.47 | 37.23 | |
20 | BioDrugs | journal | 1.486 Q1 | 79 | 48 | 120 | 2573 | 568 | 114 | 4.12 | 53.60 | 51.72 | |
21 | CNS Neuroscience and Therapeutics | journal | 1.437 Q1 | 91 | 83 | 118 | 6890 | 558 | 110 | 4.46 | 83.01 | 35.15 | |
22 | International Journal of Antimicrobial Agents | journal | 1.388 Q1 | 154 | 254 | 968 | 6693 | 3298 | 701 | 3.49 | 26.35 | 39.98 | |
23 | Pharmacoepidemiology and Drug Safety | journal | 1.382 Q1 | 109 | 177 | 506 | 4705 | 1414 | 464 | 2.72 | 26.58 | 46.37 | |
24 | British Journal of Clinical Pharmacology | journal | 1.220 Q1 | 167 | 240 | 706 | 8650 | 2304 | 539 | 3.05 | 36.04 | 38.32 | |
25 | Journal of Psychopharmacology | journal | 1.194 Q1 | 135 | 166 | 501 | 10159 | 1617 | 451 | 3.18 | 61.20 | 36.98 | |
26 | Trials | journal | 1.178 Q1 | 98 | 266 | 314 | 9895 | 932 | 302 | 2.98 | 37.20 | 38.71 | |
27 | Expert Review of Neurotherapeutics | journal | 1.162 Q1 | 98 | 175 | 490 | 13715 | 1705 | 407 | 3.58 | 78.37 | 30.02 | |
28 | Pharmaceutische Weekblad Wetenschappelijk Platform | journal | 1.100 Q1 | 2 | 0 | 10 | 0 | 3 | 10 | 0.00 | 0.00 | 0.00 | |
29 | Cancer Chemotherapy and Pharmacology | journal | 1.071 Q1 | 122 | 356 | 811 | 11313 | 2560 | 796 | 3.06 | 31.78 | 32.61 | |
30 | European Journal of Clinical Pharmacology | journal | 1.047 Q1 | 123 | 185 | 519 | 5482 | 1587 | 445 | 2.83 | 29.63 | 42.12 | |
31 | Expert Review of Anticancer Therapy | journal | 1.041 Q1 | 85 | 207 | 535 | 12125 | 1422 | 457 | 2.75 | 58.57 | 25.77 | |
32 | HIV Clinical Trials | journal | 1.021 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
33 | Cardiovascular Drugs and Therapy | journal | 1.016 Q1 | 79 | 77 | 187 | 3384 | 489 | 154 | 2.85 | 43.95 | 25.28 | |
34 | Human Psychopharmacology | journal | 0.997 Q1 | 86 | 85 | 235 | 3239 | 821 | 226 | 3.13 | 38.11 | 32.36 | |
35 | Targeted Oncology | journal | 0.985 Q1 | 59 | 29 | 98 | 1731 | 266 | 85 | 3.89 | 59.69 | 42.11 | |
36 | AIDS Research and Therapy | journal | 0.983 Q1 | 49 | 43 | 103 | 1338 | 258 | 103 | 2.26 | 31.12 | 44.27 | |
37 | Expert Opinion on Emerging Drugs | journal | 0.973 Q1 | 54 | 45 | 135 | 5658 | 526 | 135 | 3.97 | 125.73 | 26.67 | |
38 | Investigational New Drugs | journal | 0.969 Q1 | 97 | 175 | 249 | 5504 | 691 | 248 | 2.50 | 31.45 | 35.69 | |
39 | Drugs and Aging | journal | 0.919 Q2 | 109 | 91 | 255 | 5034 | 849 | 245 | 3.25 | 55.32 | 39.49 | |
40 | Cardiology | journal | 0.906 Q2 | 72 | 141 | 419 | 3004 | 639 | 317 | 1.51 | 21.30 | 24.77 | |
41 | Pharmaceutical Statistics | journal | 0.906 Q2 | 46 | 79 | 94 | 1629 | 164 | 90 | 1.60 | 20.62 | 18.54 | |
42 | European Journal of Contraception and Reproductive Health Care | journal | 0.882 Q2 | 53 | 61 | 198 | 1604 | 320 | 164 | 1.30 | 26.30 | 63.76 | |
43 | Expert Opinion on Drug Safety | journal | 0.863 Q2 | 90 | 86 | 229 | 5576 | 737 | 208 | 3.52 | 64.84 | 31.33 | |
44 | Inflammopharmacology | journal | 0.849 Q2 | 68 | 36 | 102 | 1754 | 311 | 99 | 2.47 | 48.72 | 29.91 | |
45 | Pharmacopsychiatry | journal | 0.834 Q2 | 84 | 62 | 212 | 3056 | 451 | 173 | 2.16 | 49.29 | 25.31 | |
46 | Therapeutic Advances in Respiratory Disease | journal | 0.809 Q2 | 50 | 34 | 100 | 2123 | 277 | 98 | 2.48 | 62.44 | 30.28 | |
47 | Expert Opinion on Pharmacotherapy | journal | 0.800 Q2 | 93 | 259 | 847 | 18824 | 2415 | 814 | 2.99 | 72.68 | 30.37 | |
48 | Journal of Infection and Chemotherapy | journal | 0.784 Q2 | 72 | 189 | 245 | 3326 | 504 | 234 | 1.96 | 17.60 | 18.45 | |
49 | BMC Pharmacology | journal | 0.766 Q2 | 48 | 14 | 56 | 500 | 150 | 56 | 2.69 | 35.71 | 44.00 | |
50 | American Journal of Cardiovascular Drugs | journal | 0.757 Q2 | 60 | 45 | 132 | 2142 | 328 | 121 | 2.31 | 47.60 | 25.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®